Updates are available Correction dated 2019-12-17
Click to view Correction: https://doi.org/10.1038/s41593-019-0553-6
-
Authors
,
Kaufmann, Tobias https://orcid.org/0000-0002-4003-1018
van der Meer, Dennis https://orcid.org/0000-0002-0466-386X
Doan, Nhat Trung
Schwarz, Emanuel
Lund, Martina J.
Agartz, Ingrid
Alnæs, Dag https://orcid.org/0000-0001-7361-5418
Barch, Deanna M.
Baur-Streubel, Ramona
Bertolino, Alessandro
Bettella, Francesco
Beyer, Mona K.
Bøen, Erlend
Borgwardt, Stefan https://orcid.org/0000-0002-5792-3987
Brandt, Christine L.
Buitelaar, Jan https://orcid.org/0000-0001-8288-7757
Celius, Elisabeth G. https://orcid.org/0000-0002-9127-6488
Cervenka, Simon
Conzelmann, Annette
Córdova-Palomera, Aldo
Dale, Anders M.
de Quervain, Dominique J. F.
Di Carlo, Pasquale https://orcid.org/0000-0002-5150-5274
Djurovic, Srdjan https://orcid.org/0000-0002-8140-8061
Dørum, Erlend S.
Eisenacher, Sarah
Elvsåshagen, Torbjørn
Espeseth, Thomas https://orcid.org/0000-0001-9076-6365
Fatouros-Bergman, Helena
Flyckt, Lena
Franke, Barbara https://orcid.org/0000-0003-4375-6572
Frei, Oleksandr
Haatveit, Beathe
Håberg, Asta K.
Harbo, Hanne F.
Hartman, Catharina A.
Heslenfeld, Dirk
Hoekstra, Pieter J.
Høgestøl, Einar A.
Jernigan, Terry L.
Jonassen, Rune
Jönsson, Erik G.
Kirsch, Peter https://orcid.org/0000-0002-0817-1248
Kłoszewska, Iwona
Kolskår, Knut K.
Landrø, Nils Inge
Le Hellard, Stephanie
Lesch, Klaus-Peter https://orcid.org/0000-0001-8348-153X
Lovestone, Simon
Lundervold, Arvid https://orcid.org/0000-0002-0032-4182
Lundervold, Astri J. https://orcid.org/0000-0002-6819-6164
Maglanoc, Luigi A.
Malt, Ulrik F. https://orcid.org/0000-0002-9881-2511
Mecocci, Patrizia
Melle, Ingrid
Meyer-Lindenberg, Andreas https://orcid.org/0000-0001-5619-1123
Moberget, Torgeir
Norbom, Linn B.
Nordvik, Jan Egil
Nyberg, Lars
Oosterlaan, Jaap
Papalino, Marco
Papassotiropoulos, Andreas
Pauli, Paul https://orcid.org/0000-0003-0692-6720
Pergola, Giulio https://orcid.org/0000-0002-9193-1841
Persson, Karin
Richard, Geneviève
Rokicki, Jaroslav
Sanders, Anne-Marthe
Selbæk, Geir
Shadrin, Alexey A.
Smeland, Olav B. https://orcid.org/0000-0002-3761-5215
Soininen, Hilkka
Sowa, Piotr
Steen, Vidar M.
Tsolaki, Magda
Ulrichsen, Kristine M.
Vellas, Bruno
Wang, Lei https://orcid.org/0000-0003-3870-3388
Westman, Eric https://orcid.org/0000-0002-3115-2977
Ziegler, Georg C. https://orcid.org/0000-0001-9411-3169
Zink, Mathias
Andreassen, Ole A. https://orcid.org/0000-0002-4461-3568
Westlye, Lars T. https://orcid.org/0000-0001-8644-956X
- License Information
-
More Information
Article History
Received: 28 August 2018
Accepted: 22 July 2019
First Online: 24 September 2019
Change Date: 17 December 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: Some authors received educational speaker’s honoraria from Lundbeck (O.A.A., A.B., T.E., M.Z., N.I.L.), Sunovion (O.A.A.), Shire (B.F.), Medice (B.F.), Otsuka (A.B., M.Z.), Janssen (A.B.), Roche (M.Z.), Ferrer (M.Z.), Trommsdorff (M.Z.) and Servier (M.Z.), all unrelated to this work. A.B. is a stockholder of Hoffmann-La Roche and has received consultant fees from Biogen Idec. S.L. is currently an employee of Janssen-Cilag, but contribution to this work was completed prior to this employment. E.A.H., E.G.C., M.K.B., P.S., and H.F.H. have received travel support, honoraria for advice and/or lecturing from Almirall (E.G.C.), Biogen Idec (E.G.C., H.F.H., M.K.B.), Sanofi-Genzyme (E.G.C., H.F.H., E.A.H.), Merck (E.G.C., H.F.H., E.A.H., P. S.), Novartis (E.G.C., H.F.H., M.K.B.), Roche (E.G.C., H.F.H.), Sanofi-Aventis (E.G.C., H.F.H.) and Teva (E.G.C., H.F.H.). E.G.C. anf H.F.H. have received unrestricted research grants from Novartis (E.G.C., H.F.H.), Biogen Idec (E.G.C.) and Sanofi-Genzyme (E.G.C.). G.P. has been the academic supervisor of a Roche collaboration grant (years 2015-2016) that funds his salary. None of the mentioned external parties had any role in the analysis, writing or decision to publish this work. All other authors declare no competing interests.
